These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 17545356

  • 1. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F, German Cystic Fibrosis Growth Hormone Study Group.
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [Abstract] [Full Text] [Related]

  • 2. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 4. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
    Efrati O, Mei-Zahav M, Rivlin J, Kerem E, Blau H, Barak A, Bujanover Y, Augarten A, Cochavi B, Yahav Y, Modan-Moses D.
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL, Sammut PH, Judy CG, Colombo JL.
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition.
    Hardin DS, Rice J, Ahn C, Ferkol T, Howenstine M, Spears S, Prestidge C, Seilheimer DK, Shepherd R.
    J Pediatr; 2005 Mar; 146(3):324-8. PubMed ID: 15756212
    [Abstract] [Full Text] [Related]

  • 7. Effect of high-dose ibuprofen in patients with cystic fibrosis.
    Konstan MW, Byard PJ, Hoppel CL, Davis PB.
    N Engl J Med; 1995 Mar 30; 332(13):848-54. PubMed ID: 7503838
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial.
    Hardin DS, Ellis KJ, Dyson M, Rice J, McConnell R, Seilheimer DK.
    J Pediatr; 2001 Nov 30; 139(5):636-42. PubMed ID: 11713439
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 30; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human growth hormone in the treatment of patients with cystic fibrosis.
    Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, White CM.
    Pediatrics; 2010 Nov 30; 126(5):e1211-26. PubMed ID: 20921071
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis.
    Hardin DS, Stratton R, Kramer JC, Reyes de la Rocha S, Govaerts K, Wilson DP.
    Horm Metab Res; 1998 Oct 30; 30(10):636-41. PubMed ID: 9851673
    [Abstract] [Full Text] [Related]

  • 12. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.
    Eubanks V, Koppersmith N, Wooldridge N, Clancy JP, Lyrene R, Arani RB, Lee J, Moldawer L, Atchison J, Sorscher EJ, Makris CM.
    J Pediatr; 2002 Apr 30; 140(4):439-44. PubMed ID: 12006958
    [Abstract] [Full Text] [Related]

  • 13. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
    Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM.
    N Engl J Med; 2000 Mar 23; 342(12):851-9. PubMed ID: 10727589
    [Abstract] [Full Text] [Related]

  • 14. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA, Colombo JL, Brooks MA, Smay JR, Greger NG, Sammut PH, Bier DM.
    Pediatr Pulmonol; 1996 Aug 23; 22(2):90-5. PubMed ID: 8875581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
    Dodd JD, Barry SC, Daly LE, Gallagher CG.
    J Cyst Fibros; 2005 May 23; 4(2):101-5. PubMed ID: 15978535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
    Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, Mathews D, Gorden J, Schaberg A, Williams J, Ramsey B, Cystic Fibrosis Foundation Therapeutics Development Network.
    Pediatr Pulmonol; 2005 Apr 23; 39(4):339-48. PubMed ID: 15704203
    [Abstract] [Full Text] [Related]

  • 19. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V, Haagensen AL, Carter B, Fedorowicz Z, Houston BW.
    Cochrane Database Syst Rev; 2015 May 20; (5):CD008901. PubMed ID: 25991406
    [Abstract] [Full Text] [Related]

  • 20. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
    Lands LC, Milner R, Cantin AM, Manson D, Corey M.
    J Pediatr; 2007 Sep 20; 151(3):249-54. PubMed ID: 17719932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.